Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis

Recent studies have demonstrated significant molecular parallels between atopic dermatitis and alopecia areata as predominantly TH2 ‐mediated diseases. This case report highlights the potential for Dupilumab as a targeted biologic therapy in both atopic dermatitis and alopecia areata. AbstractRecent studies have demonstrated significant molecular parallels between atopic dermatitis and alopecia areata as predominantly TH2 ‐mediated diseases. This case report highlights the potential for Dupilumab as a targeted biologic therapy in both atopic dermatitis and alopecia areata.

Source: Clinical Case Reports - May 24, 2020 Category: General Medicine Authors: John E. Call, Sakshi Sahni, Kathryn A. Zug Tags: CASE REPORT Source Type: research